Internal Medicine, Infectious Disease · Northampton, MA
NPI
1801855242
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
22 Atwood Dr
Northampton, MA, 01060
Phone (413) 582-9186
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
684 services
Medicare patients, 2024
251
Average age 75
Drug cost, 2024
$798K
371 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eric V Granowitz was code 99232 (hospital e&m - subsequent), 142 times for 102 patients. In total Eric V Granowitz billed 684 services in 21 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 142 | 102 | $59.12 | $8,394 |
| 99233 Hospital E&M - Subsequent | Facility | 111 | 74 | $91.47 | $10K |
| 99222 Hospital E&M - Initial | Facility | 103 | 99 | $96.56 | $9,946 |
| 99231 Hospital E&M - Subsequent | Facility | 66 | 50 | $36.78 | $2,427 |
| 99221 Hospital E&M - Initial | Facility | 39 | 39 | $55.59 | $2,168 |
| 99443 Telephone Services | Office | 35 | 23 | $92.92 | $3,252 |
| 99223 Hospital E&M - Initial | Facility | 35 | 35 | $131.10 | $4,588 |
| 99215 Office E&M - Established | Office | 33 | 27 | $136.87 | $4,517 |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 33 | 22 | $23.92 | $789 |
| 99213 Office E&M - Established | Office | 17 | 14 | $69.08 | $1,174 |
| 99214 Office E&M - Established | Office | 15 | 14 | $83.85 | $1,258 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 15 | 14 | $13.05 | $196 |
By year: 2022 $67K for 765 services; 2023 $55K for 649 services; 2024 $52K for 684 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eric V Granowitz prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 84 prescriptions and refills. In total Eric V Granowitz wrote 371 Medicare prescriptions that cost $798K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 84 | 92 | 11 | $378K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 29 | 29 | Under 11 | $110K |
| Darunavir Generic | 21 | 21 | Under 11 | $6,660 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 21 | 21 | Under 11 | $84.09 |
| Amoxicillin Generic | 17 | 17 | Under 11 | $60.59 |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 17 | 17 | Under 11 | $30K |
| Ritonavir Generic | 16 | 16 | Under 11 | $725 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 16 | 24 | Under 11 | $116K |
| Rifampin Generic | 16 | 16 | Under 11 | $302 |
| Abacavir Abacavir Sulfate | 15 | 23 | Under 11 | $1,380 |
| Penicillin V Potassium Generic | 14 | 22 | Under 11 | $592 |
| Doxycycline Monohydrate Generic | 13 | 13 | Under 11 | $120 |
| Zidovudine Generic | 12 | 12 | Under 11 | $1,421 |
| Vemlidy Tenofovir Alafenamide | 12 | 12 | Under 11 | $17K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 11 | 11 | Under 11 | $40K |
Brand drugs: 183 claims; generic drugs: 188 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Eric V Granowitz were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.